Kisspeptin-10 clinical trials
Every study registered on ClinicalTrials.gov that lists Kisspeptin-10 as an intervention, as of the data edition — what is being tested, in whom, by whom, and how far it has got.
- Registered studies
- 36
- Active or recruiting
- 5
- Completed
- 23
- With posted results
- 7
- Planned or actual enrollment
- 3,980participants, summed
| Phase | Studies | Breakdown |
|---|---|---|
| Phase 1 | 11 | 7 completed, 1 active or recruiting, 3 stopped, 0 other |
| Phase 2 | 8 | 3 completed, 2 active or recruiting, 3 stopped, 0 other |
| Phase 3 | 3 | 3 completed, 0 active or recruiting, 0 stopped, 0 other |
| Not applicable | 3 | 2 completed, 1 active or recruiting, 0 stopped, 0 other |
| Observational | 11 | 8 completed, 1 active or recruiting, 0 stopped, 2 other |
Conditions studied
- Hypogonadotropic Hypogonadism10
- Reproductive Disorder4
- Kallmann Syndrome3
- Hypothalamic Amenorrhea2
- Delayed Puberty2
- GnRH Deficiency2
- Infertility2
- PCOS2
- Hyperprolactinemia2
- Polycystic Ovary Syndrome2
- Reproductive Age1
- PCOS (Polycystic Ovary Syndrome)1
Lead sponsors
- Stephanie B. Seminara, MD9
- Massachusetts General Hospital7
- Takeda2
- Vida Recoletas Sevilla2
- Imperial College London2
- Quaid-e-Azam University2
- Jagiellonian University1
- Istanbul University - Cerrahpasa1
The registry, study by study
Registration is not evidence of benefit; many registered studies never publish. Status and dates are as reported by sponsors to ClinicalTrials.gov.
| Study | Phase | Status | Start | n | Sponsor |
|---|---|---|---|---|---|
| NCT07224490Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease | Phase 1 | Recruiting | Mar 2026 | 40 | Stephanie B. Seminara, MD |
| NCT07224438Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea | Phase 2 | Recruiting | Dec 2025 | 20 | Stephanie B. Seminara, MD |
| NCT06793098Functional Proteins in Polycystic Ovary Syndrome | Observational | Recruiting | Jan 2025 | 100 | Jagiellonian University |
| NCT05896293Kisspeptin Administration Subcutaneously to Patients With IHH | Phase 2 | Recruiting | Feb 2023 | 36 | Stephanie B. Seminara, MD |
| NCT02081924Reproductive Hormones During Sustained Administration of Kisspeptin | N/A | Recruiting | Apr 2014 | 76 | Imperial College London |
| NCT06501729Kissing as a Protective Factor Against Acidic pH in Saliva | N/A | Completed | Jul 2024 | 33 | Universidad Catolica Santiago de Guayaquil |
| NCT06545994A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS | Observational | Unknown status | Jun 2024 | 180 | Fudan University |
| NCT05901467Recall by Genotype: Neuropeptide StimulationResults posted | Phase 1 | Terminated | Oct 2023 | 16 | Stephanie B. Seminara, MD |
| NCT05971849Dampening the Reproductive Axis With Continuous Kisspeptin | Phase 1 | Completed | Oct 2023 | 8 | Stephanie B. Seminara, MD |
| NCT05835089Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases | Observational | Unknown status | May 2023 | 50 | Sohag University |
| NCT05633966Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders | Phase 1 | Completed | Dec 2022 | 13 | Stephanie B. Seminara, MD |
| NCT05456854Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp | Phase 1 | Withdrawn | Jun 2022 | 0 | Massachusetts General Hospital |
| NCT04958109Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance TestResults posted | Phase 1 | Completed | Oct 2021 | 16 | Massachusetts General Hospital |
| NCT05971836The Molecular Basis of Inherited Reproductive Disorders | Observational | Completed | Jan 2021 | 854 | Stephanie B. Seminara, MD |
| NCT06775990Molecules Associated with Pediatric Obesity | Observational | Completed | Jun 2020 | 60 | Istanbul University - Cerrahpasa |
| NCT03877939Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy | Observational | Completed | Sep 2019 | 433 | Vida Recoletas Sevilla |
| NCT04532801Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance | Phase 1 | Withdrawn | Sep 2019 | 0 | Stephanie B. Seminara, MD |
| NCT04648969Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic HypogonadismResults posted | Phase 2 | Completed | May 2019 | 18 | Stephanie B. Seminara, MD |
| NCT03940495Serum Kisspeptin: a Predictive Marker of Miscarriage or Not? | Observational | Completed | May 2019 | 182 | ShangHai Ji Ai Genetics & IVF Institute |
| NCT04371991Kisspeptin Levels in Early Pregnancy | Observational | Completed | Jan 2019 | 88 | Semra Yuksel |
| NCT02956447Administration of Kisspeptin in Patients With HyperprolactinemiaResults posted | Phase 2 | Completed | Nov 2017 | 36 | Massachusetts General Hospital |
| NCT04012632Kisspeptin/GPR54 Pathway and Early Puberty | Observational | Completed | Sep 2016 | 628 | Shenzhen Center for Disease Control and Prevention |
| NCT03018314Serum Kisspeptin Levels in Infertile Women | Observational | Completed | Jun 2016 | 90 | Bakirkoy Dr. Sadi Konuk Research and Training Hospital |
| NCT02381288Effects of TAK-448 in Middle-aged and Older Men With Low TestosteroneResults posted | Phase 2 | Terminated | Sep 2015 | 17 | Takeda |
| NCT02369796A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic HypogonadismResults posted | Phase 2 | Terminated | Feb 2015 | 15 | Takeda |
| NCT03315325Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men | Phase 3 | Completed | Aug 2014 | 15 | Quaid-e-Azam University |
| NCT03286517Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys. | Phase 3 | Completed | Jun 2014 | 30 | Ghulam Nabi |
| NCT01952782Neuropeptides in Human Reproduction | Phase 1 | Completed | Apr 2014 | 61 | Massachusetts General Hospital |
| NCT02877992Tachykinin and Kisspeptin Expression in Human Granulosa and Cumulus Cells | N/A | Completed | Jan 2014 | 236 | Vida Recoletas Sevilla |
| NCT03771326KP-10 and Insulin Secretion in Men | Phase 3 | Completed | Oct 2013 | 14 | Quaid-e-Azam University |
| NCT01956851Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus | Observational | Completed | Sep 2013 | 55 | Ganga Care Hospital, Nagpur |
| NCT01438034Kisspeptin in the Evaluation of Delayed Puberty | Phase 1 | Completed | Jun 2013 | 24 | Massachusetts General Hospital |
| NCT01667406The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) TreatmentResults posted | Phase 2 | Completed | Jun 2012 | 175 | Imperial College London |
| NCT01438073Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling | Phase 1 | Completed | Sep 2011 | 96 | Massachusetts General Hospital |
| NCT01132404Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | Phase 1/Phase 2 | Terminated | Nov 2010 | 9 | Millennium Pharmaceuticals, Inc. |
| NCT00914823Kisspeptin Administration in the Adult | Phase 1 | Completed | Jun 2009 | 256 | Massachusetts General Hospital |
Run this search on ClinicalTrials.gov → Query term: kisspeptin-10 OR kisspeptin